We found that 21.4% of the patients with LC had detectable levels of ADAMTS13:INH, and the proportion of the patients with detectable levels of ADAMTS13:INH increased as LC progressed. The gene discussed is ADAMTS13; the disease is laryngotracheoesophageal cleft.